|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Accounts receivable, net | ||||||||||
| Current contract assets, net | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Receivables from related parties | ||||||||||
| Related Party | ||||||||||
| Total receivables from related parties | ||||||||||
| Prepaid income taxes | ||||||||||
| Total current assets | ||||||||||
| Property, equipment and leasehold improvements, net | ||||||||||
| Goodwill | ||||||||||
| Finite-Lived Intangible Assets, Net | ||||||||||
| Non-current contract assets, net | ||||||||||
| Contract costs | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Deferred income tax assets | ||||||||||
| Other non-current assets | ||||||||||
| Total assets | ||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||
| Total liabilities | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Liability from foreign currency forward contract | ||||||||||
| Due to related parties | ||||||||||
| Related Party | ||||||||||
| Total due to related parties | ||||||||||
| Current operating lease liabilities | ||||||||||
| Income taxes payable | ||||||||||
| Current borrowings | ||||||||||
| Current contract liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Non-current contract liabilities | ||||||||||
| Deferred income tax liabilities | ||||||||||
| Non-current operating lease liabilities | ||||||||||
| Non-current borrowings, net | ||||||||||
| Other non-current liabilities | ||||||||||
| Stockholders' equity: | ||||||||||
| Common Stock, Value, Issued | ||||||||||
| Stockholder receivable | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Treasury Stock, Common, Shares | ||||||||||
| Treasury Stock, Value | ||||||||||
| Total stockholders’ equity | ||||||||||
| Total liabilities and stockholders’ equity | ||||||||||
| Common stock, par value (in dollars per share) | ||||||||||
| Common stock, authorized | ||||||||||
| Common stock, issued | ||||||||||
| Common stock, outstanding |
Loading...